Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
291 results
  1. Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK66007
    ... based chemotherapy and the addition of poly (ADP-ribose) polymerase (PARP) inhibitors to induction and/or consolidation ... paclitaxel. Bevacizumab, other targeted drugs, and poly (ADP-ribose) polymerase (PARP) inhibitors with or without chemotherapy Evidence ( ...
  2. Breast Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65744
    ... first line is an appropriate choice. Poly (ADP-ribose) polymerase (PARP) inhibitor therapy Patients with hormone receptor- ...
  3. MedlinePlus Drug Information: Rucaparib 
    https://medlineplus.gov/druginfo/meds/a617002.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  4. MedlinePlus Drug Information: Niraparib 
    https://medlineplus.gov/druginfo/meds/a617007.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  5. MedlinePlus Drug Information: Talazoparib 
    https://medlineplus.gov/druginfo/meds/a618070.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by stopping or ...
  6. MedlinePlus Drug Information: Niraparib and Abiraterone 
    https://medlineplus.gov/druginfo/meds/a623037.html
    ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
  7. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : final evidence report ... Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
  8. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... 759.646.138.124.070.125 Adenosine Diphosphate Ribose D03.633.100.759.646.138.124.070.125.040 O-Acetyl-ADP-Ribose D03.633.100.759.646.138.124.070.125.195 Cyclic ADP-Ribose D03.633.100.759.646.138.180 Adenosine ...
  9. BRCA1 and BRCA2: Cancer Risks and Management (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK589498
    ... benefit of platinum chemotherapy with a poly (ADP-ribose) polymerase (PARP) inhibitor (veliparib). PCR rates for BRCA1/ ... Yap TA, et al.: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N ...
  10. pdf2018NewHeadingsSingleColumn508.pdf 
    https://www.nlm.nih.gov/.../2018NewHeadingsSingleColumn508.pdf
    ... Post-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE. Tree locations: Protein Processing, Post-Translational G02.111. ... Binding Factor A repressor protein with poly(ADP)-ribose binding activity that binds CHROMATIN and DNA; its ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last